Back

PRIME Education, Inc. (PRIME®)

  • Caregiver Burden
  • Delayed Diagnosis
  • Genetic Testing
  • Muscular Atrophy, Spinal
  • Neonatal Screening

Decoding Spinal Muscular Atrophy (SMA): From Phenotypic Diversity to Early Diagnosis

Spinal muscular atrophy (SMA) manifests across a broad clinical spectrum, with functional status and disease trajectory varying widely among individuals. Understanding this heterogeneity is essential to anticipate progression, manage patient and caregiver burden, and optimize outcomes. Early diagnosis remains critical; newborn screening (NBS) and confirmatory genetic testing have transformed identification and management, yet real-world implementation gaps persist. Tune in to the first episode of our four-part video podcast series to hear from two leading experts as they unpack the diverse clinical presentations of SMA, examine the impact of delayed diagnosis, and discuss how early detection through NBS can reshape the course of care. Watch the full video podcast or listen on the go with the audio-only version!

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Podcast / audio
  • includes On-demand / recorded video
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Dec 30, 2025
  • Last day to claim credit
    Dec 30, 2026 3 months left